e-learning
resources
Munich 2014
Tuesday, 09.09.2014
New mechanisms in the pathogenesis of asthma and other lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival
D. Cunoosamy, X. H. Zhou, M. Rehnberg, K. Svensson, K. Sandberg (Mölndal, Sweden)
Source:
International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Session:
New mechanisms in the pathogenesis of asthma and other lung diseases
Session type:
Thematic Poster Session
Number:
3863
Disease area:
Airway diseases
Abstract
Expression of fractalkine (CX3CL1) is elevated in asthma and may be involved in controlling the inflammatory response in lungs by regulating influx of leukocytes, cell survival and function of fractalkine receptor (CX3CR1) expressing cells. In this study, the cellular distribution of CX3CR1 and CX3CL1 in lungs from asthmatics was determined by immunohistochemistry using validated antibodies. CX3CR1 is expressed in bronchial epithelial cells, endothelial cells, CD3
+
cells, CD4
+
cells, CD207
+
cells, CD68
+
cells, and mast cells. Interestingly, very few of the CD8
+
cells that were located to lamina propria and submucosa expressed CX3CR1 whereas within the bronchial epithelium in asthmatics, numerous CD8
+
cells were co-expressing CX3CR1. Overall, no difference in expression intensity was observed comparing lung biopsies from healthy volunteers and asthmatics, independent of disease severity (GINA). CX3CL1 was expressed in airway epithelia with highest intensity at the apical side facing the airway lumen, inflammatory cells in lamina propria and smooth muscle cells. Steroid treatment did not affect the expression pattern, nor the intensity in staining.The changed expression pattern of CX3CR1 expressing cells in asthmatics suggest that CX3CR1 signaling could be of importance for cellular redistribution in inflamed airways. A potent and highly selective small molecule CX3CR1 antagonist was therefore used to study the role of CX3CL1 to mediate cell survival in CX3CR1 expressing leukocytes. The data suggest that CX3CR1 signaling does enhance cell survival and that pharmacological inhibition of CX3CR1 signaling may be efficacious in reducing chronic airway inflammation and hyper responsiveness.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Cunoosamy, X. H. Zhou, M. Rehnberg, K. Svensson, K. Sandberg (Mölndal, Sweden). Expression of CX3CL1 and CX3CR1 in human asthmatic lung in relation to cell survival. Eur Respir J 2014; 44: Suppl. 58, 3863
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Omalizumab prevents smooth muscle cell growth induced by asthmatic serum
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
Modulation of PD-1 and PD-L1 expression in response to acute viral infection of human lung tissue
Source: International Congress 2014 – Cell biology 2014
Year: 2014
ADAM9 is upregulated in human COPD lungs and in human and murine lung in response to cigarette smoke
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by cytotoxic/ pro-inflammatory lymphocytes
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014
Functional phenotype of immune response and alveolar macrophages phenotype in pulmonary sarcoidosis
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Evidence for a novel kit adhesion domain mediating human mast cell adhesion to structural airway cells
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Soluble FasL and Fas+ lymphocytes in peripheral blood of non-smoking patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Different roles for PI3Kgamma and δ in asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
MicroRNA-146a and microRNA-155 expression in induced sputum of allergic asthmatics
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
TNF-a induces cPLA
2
expression via Jak2/PDGFR-dependent Elk-1/p300 activation in human lung epithelial cells
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
Macrophage migration inhibitory factor (MIF), a biomarker in COPD?
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Modulation of neutrophil functionalities by indacaterol and their relevance for chronic lung diseases
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
CEACAM6-high airway neutrophils and epithelial cells are a feature of severe asthma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
Crosstalk between epithelium and fibroblasts; implications for COPD
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
Phenotypes of alveolar macrophages in normal human lung and their polarization with disease
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept